<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[170, 172] spotty calcification<br>[173, 174] older<br>[209, 211] diabetes mellitus<br>[223, 225] myocardial infarction<br>[239, 249] lower on-treatment high-density lipoprotein cholesterol levels<br>[273, 278] atheroma volume (PAV)<br>[324, 328] greater progression of PAV<br>[384, 386] coronary atherosclerosis<br></td>
<td width=33%>
[67, 73] incidence of ischemic cardiovascular events.<br>[170, 172] spotty calcification<br>[173, 174] older<br>[209, 211] diabetes mellitus<br>[223, 225] myocardial infarction<br>[239, 249] lower on-treatment high-density lipoprotein cholesterol levels<br>[273, 278] atheroma volume (PAV)<br>[294, 297] total atheroma volume<br>[324, 328] greater progression of PAV<br>[357, 360] disease progression,<br>[380, 390] more extensive and diffuse coronary atherosclerosis and accelerated disease progression<br></td>
<td width=33%>
[6, 12] accelerated progression of coronary atherosclerosis:<br>[28, 30] atheroma progression<br>[66, 73] increased incidence of ischemic cardiovascular events.<br>[101, 110] evaluation of atheroma burden with intravascular ultrasound imaging.<br>[138, 143] Clinical characteristics and disease progression<br>[170, 174] spotty calcification were older<br>[207, 211] history of diabetes mellitus<br>[222, 225] and myocardial infarction<br>[271, 278] greater percent atheroma volume (PAV)<br>[294, 297] total atheroma volume<br>[324, 328] greater progression of PAV<br>[345, 355] intensive low-density lipoprotein cholesterol and blood pressure lowering<br>[357, 360] disease progression,<br>[380, 390] more extensive and diffuse coronary atherosclerosis and accelerated disease progression<br></td>
</tr>
